Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially, for women with early breast cancer.
By Sandra Hanner
Advertisement
Articles by By Sandra Hanner
Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially for women with early breast cancer.
Aflibercept added to FOLFIRI chemotherapy improved PFS and OS in previously treated patients with metastatic colorectal cancer.
Panitumumab + chemo improves OS and PFS in patients with metastatic carcinoma of the head and neck that were negative for HPV.
Patients with liver metastases from uveal melanoma had improved survival after treatment with percutaneous hepatic perfusion (PHP).
Advertisement
Latest Updated Articles
- Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients
Published: September 26th 2011 | Updated:
Novel Infusion Approach Significantly Delays Progression in Uveal Melanoma Patients With Liver MetastasesPublished: September 24th 2011 | Updated:
- Panitumumab Extends Progression-Free Survival in HPV-Negative Subset of Advanced Head and Neck Cancer
Published: September 25th 2011 | Updated:
- Aflibercept Improves Survival in Metastatic Colorectal Cancer Patients
Published: September 26th 2011 | Updated:
- Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients
Published: September 26th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5